We are live on ! Find out more
CRMD icon

CorMedix
CRMD

17 hedge funds and large institutions have $4.25M invested in CorMedix in 2014 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more funds holding

Funds holding: 11 → 17 (+6)

7% more capital invested

Capital invested by funds: $3.96M → $4.25M (+$292K)

0.07% more ownership

Funds ownership: 1.91% → 1.99% (+0.07%)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
17
Holders Change
+6
Holders Change %
+54.55%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
–
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WT
Washington Trust
Rhode Island
+$39.4K
2
VKH
Virtu KCG Holdings
New York
+$27.8K
3
BIT
BlackRock Institutional Trust
California
+$9.8K
4
Bank of America
Bank of America
North Carolina
+$7.96K
5
NPC
National Planning Corporation
California
+$1.59K

Top Sellers

Rank Fund Capital Flow
1
GLRA
Gerald L. Ray & Associates
Texas
-$1.59K
2
Citigroup
Citigroup
New York
-$80
3
Goldman Sachs
Goldman Sachs
New York
-$64

CRMD Hedge Fund Activity: Q4 2014 in Review

17 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q4 2014, worth a combined $4.25M — up 7.4% from $3.96M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new CRMD positions and 0 closed out — a net gain of 6 holders — while 0 added to existing stakes and 3 trimmed.

The largest buyer was Washington Trust, opening a new position worth an estimated $39.4K. The largest seller was Gerald L. Ray & Associates, cutting an estimated $1.59K.

  • 17 institutional investors held CorMedix (CRMD) as of Q4 2014, up from 11 in Q3 2014.
  • Funds reported $4.25M of CorMedix stock for Q4 2014, up 7.4% quarter-over-quarter.
  • 6 funds opened new CorMedix positions in Q4 2014 and 0 closed out, a net change of +6 holders.
  • The largest CorMedix buyer in Q4 2014 was Washington Trust, an estimated $39.4K added.
  • The largest CorMedix seller in Q4 2014 was Gerald L. Ray & Associates, an estimated $1.59K sold.

Based on aggregated 13F filings for Q4 2014.